Wealth Trust Axiom LLC Contrafect Corp Transaction History

Wealth Trust Axiom LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$0.18 - $3.51 $1,435 - $27,992	7,975 Added 36.21%	30,000 $5,000
Q2 2022 Jul 27, 2022	SELL	$2.79 - $4.45 $22,320 - $35,600	-8,000 Reduced 26.64%	22,025 $67,000
Q4 2021 Feb 02, 2022	BUY	$2.47 - $4.14 $12,350 - $20,700	5,000 Added 19.98%	30,025 $78,000
Q3 2021 Oct 14, 2021	SELL	$3.19 - $4.43 $15,950 - $22,150	-5,000 Reduced 16.65%	25,025 $101,000
Q2 2021 Jul 22, 2021	BUY	$3.58 - $4.9 $53,700 - $73,500	15,000 Added 99.83%	30,025 $132,000

Q1 2021 Apr 14, 2021	BUY	$4.46 - $6.68 $67,011 - $100,367	15,025 New	15,025 $72,000

49.2K

Ticker CFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,332,700
Market Cap $1.18M
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...

Get notified when there are updates to the investment portfolio of Wealth Trust Axiom LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Trust Axiom LLC with notifications on news.